Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

1.

Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.

Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G; On behalf of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Oral Oncol. 2014 Oct 6. pii: S1368-8375(14)00272-3. doi: 10.1016/j.oraloncology.2014.09.011. [Epub ahead of print]

PMID:
25301563
[PubMed - as supplied by publisher]
2.

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.

Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA.

PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.

PMID:
25203931
[PubMed - in process]
Free PMC Article
3.
4.

Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.

Coffin CS, Mulrooney-Cousins PM, Osiowy C, van der Meer F, Nishikawa S, Michalak TI, van Marle G, Gill MJ.

J Clin Virol. 2014 Aug;60(4):347-53. doi: 10.1016/j.jcv.2014.04.021. Epub 2014 May 4.

PMID:
24881491
[PubMed - in process]
5.

Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.

Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, Fätkenheuer G, Reiss P, Saag MS, Manzardo C, Grabar S, Bruyand M, Moore D, Mocroft A, Sterling TR, D'Arminio Monforte A, Hernando V, Teira R, Guest J, Cavassini M, Crane HM, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

Clin Infect Dis. 2014 Jul 15;59(2):287-97. doi: 10.1093/cid/ciu261. Epub 2014 Apr 24.

PMID:
24771333
[PubMed - in process]
Free PMC Article
6.

Improving the timeliness of meticillin-resistant Staphylococcus aureus antimicrobial decolonization therapy administration: a descriptive account.

Brooks HL, Hodson J, Richardson SJ, Stezhka L, Gill MJ, Coleman JJ.

J Hosp Infect. 2014 Mar;86(3):209-15. doi: 10.1016/j.jhin.2014.01.004. Epub 2014 Feb 6.

PMID:
24560977
[PubMed - in process]
Free PMC Article
7.

Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV.

Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley S, Singhal N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, Loutfy M, Mallick R, Moorhouse R, William Cameron D.

PLoS One. 2014 Jan 21;9(1):e85607. doi: 10.1371/journal.pone.0085607. eCollection 2014.

PMID:
24465617
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Disparities in the quality of HIV care when using US Department of Health and Human Services indicators.

Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, Hogg R, Thorne JE, Klein M, Gill MJ, Sterling TR, Yehia B, Silverberg MJ, Crane H, Justice AC, Gange SJ, Moore R, Kitahata MM, Horberg MA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Clin Infect Dis. 2014 Apr;58(8):1185-9. doi: 10.1093/cid/ciu044. Epub 2014 Jan 23.

PMID:
24463281
[PubMed - in process]
9.

Increasing HIV subtype diversity and its clinical implications in a sentinel North American population.

Siemieniuk RA, Beckthold B, Gill MJ.

Can J Infect Dis Med Microbiol. 2013 Summer;24(2):69-73.

PMID:
24421804
[PubMed]
Free PMC Article
10.

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

PLoS One. 2013 Dec 18;8(12):e81355. doi: 10.1371/journal.pone.0081355. eCollection 2013.

PMID:
24367482
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The cost of antiretroviral drug resistance in HIV-positive patients.

Krentz HB, Ko K, Beckthold B, Gill MJ.

Antivir Ther. 2014;19(4):341-8. doi: 10.3851/IMP2709. Epub 2013 Dec 3.

PMID:
24296618
[PubMed - in process]
12.

Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.

van Marle G, Sharkey KA, Gill MJ, Church DL.

PLoS One. 2013 Oct 16;8(10):e75967. doi: 10.1371/journal.pone.0075967. eCollection 2013.

PMID:
24146801
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients.

Li SS, Kyei SK, Timm-McCann M, Ogbomo H, Jones GJ, Shi M, Xiang RF, Oykhman P, Huston SM, Islam A, Gill MJ, Robbins SM, Mody CH.

Cell Host Microbe. 2013 Oct 16;14(4):387-97. doi: 10.1016/j.chom.2013.09.007.

PMID:
24139398
[PubMed - indexed for MEDLINE]
Free Article
14.

The effect of churn on "community viral load" in a well-defined regional population.

Krentz HB, Gill MJ.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):190-6. doi: 10.1097/QAI.0b013e31829cef18.

PMID:
24047969
[PubMed - indexed for MEDLINE]
15.

Inactivation of the lateral habenula reduces anxiogenic behavior and cocaine seeking under conditions of heightened stress.

Gill MJ, Ghee SM, Harper SM, See RE.

Pharmacol Biochem Behav. 2013 Oct;111:24-9. doi: 10.1016/j.pbb.2013.08.002. Epub 2013 Aug 19.

PMID:
23969093
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intimate partner violence and HIV: a review.

Siemieniuk RA, Krentz HB, Gill MJ.

Curr HIV/AIDS Rep. 2013 Dec;10(4):380-9. doi: 10.1007/s11904-013-0173-9. Review.

PMID:
23943348
[PubMed - indexed for MEDLINE]
17.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA.

J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373. Epub 2013 Jul 31.

PMID:
23904290
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.

Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB.

AIDS. 2013 Sep 24;27(15):2385-401. doi: 10.1097/QAD.0b013e328363bf56. Review.

PMID:
23751261
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The changing demographics of women living with HIV/AIDS in southern Alberta from 1982 to 2006.

Hwang L, Raffa J, Gill MJ.

Can J Infect Dis Med Microbiol. 2012 Summer;23(2):e36-40.

PMID:
23730318
[PubMed]
Free PMC Article
20.

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.

Abgrall S, Ingle SM, May MT, Costagliola D, Mercie P, Cavassini M, Reekie J, Samji H, Gill MJ, Crane HM, Tate J, Sterling TR, Antinori A, Reiss P, Saag MS, Mugavero MJ, Phillips A, Manzardo C, Wasmuth JC, Stephan C, Guest JL, Gomez Sirvent JL, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

AIDS. 2013 Mar 13;27(5):803-13. doi: 10.1097/QAD.0b013e32835cb997.

PMID:
23719350
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk